Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'biological response modifiers' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 147 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Suliman, HB; Ryan, LK; Bishop, L; Folz, RJ
      Prevention of influenza-induced lung injury in mice overexpressing extracellular superoxide dismutase

      AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
    2. Komoda, M; Kakuta, H; Takahashi, H; Fujimoto, Y; Kadoya, S; Kato, F; Hashimoto, Y
      Specific inhibitor of puromycin-sensitive aminopeptidase with a homophthalimide skeleton: Identification of the target molecule and a structure-activity relationship study

      BIOORGANIC & MEDICINAL CHEMISTRY
    3. Kita, T; Takahashi, H; Hashimoto, Y
      Thymidine phosphorylase inhibitors with a homophthalimide skeleton

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    4. Kakuta, H; Koiso, Y; Takahashi, H; Nagasawa, K; Hashimoto, Y
      Novel specific puromycin-sensitive aminopeptidase inhibitors: 3-(2,6-diethylphenyl)2,4(1H, 3H)-quinazolinedione and N-(2,6-diethylphenyl)2-amino-4H-3,1-benzoxazin-4-one

      HETEROCYCLES
    5. Law, S; Maiti, D; Palit, A; Majumder, D; Basu, K; Chaudhuri, S; Chaudhuri, S
      Facilitation of functional compartmentalization of bone marrow cells in leukemic mice by biological response modifiers: an immunotherapeutic approach

      IMMUNOLOGY LETTERS
    6. Al-Soud, YA; Al-Masoudi, NA
      Synthesis and antitumor activity of some new phthalimide analogues

      PHARMAZIE
    7. Terheyden, P; Becker, JC; Kampgen, E; Brocker, EB
      Sequential interferon-alpha 2b, interleukin-2 and fotemustine for patientswith metastatic melanoma

      MELANOMA RESEARCH
    8. Bernengo, MG; Quaglino, P; Cappello, N; Lisa, F; Osella-Abate, S; Fierro, MT
      Macrophage-mediated immunostimulation modulates therapeutic efficacy of interleukin-2 based chemoimmunotherapy in advanced metastatic melanoma patients

      MELANOMA RESEARCH
    9. Badmaev, V; Nowakowski, M
      Protection of epithelial cells against influenza A virus by a plant derived biological response modifier Ledretan-96

      PHYTOTHERAPY RESEARCH
    10. Tsuji, M; Koiso, Y; Takahashi, H; Hashimoto, Y; Endo, Y
      Modulators of tumor necrosis factor alpha production bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    11. Zlotta, AR; Schulman, CC
      Biological response modifiers for the treatment of superficial bladder tumors

      EUROPEAN UROLOGY
    12. Schamhart, DHJ; de Boer, EC; de Reijke, TM; Kurth, KH
      Urinary cytokines reflecting the immunological response in the urinary bladder to biological response modifiers: Their practical use

      EUROPEAN UROLOGY
    13. Bodey, B; Bodey, B; Siegel, SE; Kaiser, HE
      Failure of cancer vaccines: The significant limitations of this approach to immunotherapy

      ANTICANCER RESEARCH
    14. Wiltrout, RH
      Regulation and antimetastatic functions of liver-associated natural killercells

      IMMUNOLOGICAL REVIEWS
    15. Rouveix, B; Giroud, JP
      Clinical pharmacology of recombinant cytokines

      THERAPIE
    16. Young, SH; Dong, WJ; Jacobs, RR
      Observation of a partially opened triple-helix conformation in 1 -> 3-beta-glucan by fluorescence resonance energy transfer spectroscopy

      JOURNAL OF BIOLOGICAL CHEMISTRY
    17. Takahashi, H; Sou, S; Yamasaki, R; Sodeoka, M; Hashimoto, Y
      alpha-glucosidase inhibitors with a phthalimide skeleton: Structure-activity relationship study

      CHEMICAL & PHARMACEUTICAL BULLETIN
    18. Toge, T
      Effectiveness of immunochemotherapy for gastric cancer: A review of the current status

      SEMINARS IN SURGICAL ONCOLOGY
    19. Shimazawa, R; Takayama, H; Fujimoto, Y; Komoda, M; Dodo, K; Yamasaki, R; Shirai, R; Koiso, Y; Miyata, K; Kato, F; Kato, M; Miyachi, H; Hashimoto, Y
      Novel small molecule nonpeptide aminopeptidase N inhibitors with a cyclic imide skeleton

      JOURNAL OF ENZYME INHIBITION
    20. O'Dell, JR; Scott, DL
      Rheumatoid arthritis: new developments in the use of existing therapies

      RHEUMATOLOGY
    21. Ueno, T; Sujaku, K; Tamaki, S; Ogata, R; Kin, M; Nakamura, T; Sakamoto, M; Torimura, T; Mitsuyama, K; Sakisaka, S; Sata, M; Tanikawa, K
      OK-432 treatment increases matrix metalloproteinase-9 production and improves dimethylnitrosamine-induced liver cirrhosis in rats

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    22. Oldham, RK
      Fundamentally different

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    23. Morell-Quadreny, L; Fenollosa-Entrena, B; Clar-Blanch, F; Navarro-Fos, S; Llombart-Bosch, A
      Expression of type I interferon receptor in renal cell carcinoma

      ONCOLOGY REPORTS
    24. Toma, S; Ugolini, D; Palumbo, R
      Tamoxifen in the treatment of metastatic malignant melanoma: Still a controversy? (Review)

      INTERNATIONAL JOURNAL OF ONCOLOGY
    25. Kagechika, H; Komoda, M; Fujimoto, Y; Koiso, Y; Takayama, H; Kadoya, S; Miyata, K; Kato, F; Kato, M; Hashimoto, Y
      Potent homophthalimide-type inhibitors of B16F10/L5 mouse melanoma cell invasion

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    26. Hart, DA
      Augmentation of lithium-induced polydipsia in Corynebacterium parvum-PER treated mice: characterization of the response in C57BL/6 mice

      JOURNAL OF TRACE AND MICROPROBE TECHNIQUES
    27. ROSELLI M; BUONOMO O; PIAZZA A; GUADAGNI F; VECCHIONE A; BRUNETTI E; CIPRIANI C; AMADEI G; NIERODA C; GREINER JW; CASCIANI CU
      NOVEL CLINICAL APPROACHES IN MONOCLONAL ANTIBODY-BASED MANAGEMENT IN COLORECTAL-CANCER PATIENTS - RADIOIMMUNOGUIDED SURGERY AND ANTIGEN AUGMENTATION

      Seminars in surgical oncology
    28. SUJAKU K; UENO T; TORIMURA T; SATA M; TANIKAWA K
      EFFECTS OF OK-432 ON MATRIX METALLOPROTEINASE-9 EXPRESSION AND ACTIVITY IN RAT CULTURED KUPFFER CELLS

      Hepatology research
    29. KATOH R; TAKENOSHITA S; SHIMIZU Y; TANAKA S
      EFFECTS ON HOST OF MODIFIED PVP THERAPY COMBINED WITH BIOLOGICAL RESPONSE MODIFIERS IN LUNG-CANCER

      Oncology Reports
    30. COTO C; VARELA G; HERNANDEZ V; DELROSARIO M; LOPEZSAURA P
      USE OF RECOMBINANT INTERFERON-GAMMA IN PEDIATRIC-PATIENTS WITH ADVANCED JUVENILE CHRONIC ARTHRITIS

      Biotherapy
    31. Ebina, T; Fujimiya, Y
      Antitumor effect of a peptide-glucan preparation extracted from Agaricus blazei in a double-grafted tumor system in mice

      BIOTHERAPY
    32. Mastrangelo, G; Fadda, E; Milan, G
      Cancer increased after a reduction of infections in the first half of thiscentury in Italy: Etiologic and preventive implications

      EUROPEAN JOURNAL OF EPIDEMIOLOGY
    33. FUJIMIYA Y; SUZUKI Y; OSHIMAN K; KOBORI H; MORIGUCHI K; NAKASHIMA H; MATUMOTO Y; TAKAHARA S; EBINA T; KATAKURA R
      SELECTIVE TUMORICIDAL EFFECT OF SOLUBLE PROTEOGLUCAN EXTRACTED FROM THE BASIDIOMYCETE, AGARICUS-BLAZEI MURILL, MEDIATED VIA NATURAL-KILLER-CELL ACTIVATION AND APOPTOSIS

      Cancer immunology and immunotherapy
    34. SVEINBJORNSSON B; RUSHFELDT C; SELJELID R; SMEDSROD B
      INHIBITION OF ESTABLISHMENT AND GROWTH OF MOUSE-LIVER METASTASES AFTER TREATMENT WITH INTERFERON-GAMMA AND BETA-1,3-D-GLUCAN

      Hepatology
    35. NERI B; DELEONARDIS V; GEMELLI MT; DILORO F; MOTTOLA A; PONCHIETTI R; RAUGEI A; CINI G
      MELATONIN AS BIOLOGICAL RESPONSE MODIFIER IN CANCER-PATIENTS

      Anticancer research
    36. ALPAUGH RK; WEINER LM; PERSSON R; PERSSON B
      OVERVIEW OF CLINICAL-TRIALS EMPLOYING ANTIBODY-TARGETED SUPERANTIGENS

      Advanced drug delivery reviews
    37. PALLERONI AV; HAJOS S; WRIGHT RB; PALLERONI NJ
      NITRIC-OXIDE SYNTHASE INDUCTION IN LINES OF MACROPHAGES FROM DIFFERENT ANATOMICAL SITES

      Cellular and molecular biology
    38. MAEDA YY; TAKAHAMA S; YONEKAWA H
      4 DOMINANT LOCI FOR THE VASCULAR-RESPONSES BY THE ANTITUMOR POLYSACCHARIDE, LENTINAN

      Immunogenetics
    39. PINI E; ROSSI E; STRADI R
      SYNTHESIS OF NEW CYTOSINE AND THYMINE DERIVATIVES OF POTENTIAL IMMUNOMODULATORY ACTIVITY

      Synthetic communications
    40. WATANABE K; TSUGE Y; SHIMOYAMADA M; OGAMA N; EBINA T
      ANTITUMOR EFFECTS OF PRONASE-TREATED FRAGMENTS, GLYCOPEPTIDES, FROM OVOMUCIN IN HEN EGG-WHITE IN A DOUBLE GRAFTED TUMOR SYSTEM

      Journal of agricultural and food chemistry
    41. Harousseau, JL
      Methods for evaluating biological response modifiers

      BULLETIN DU CANCER
    42. THAKUR ML; LI J; DONEGAN M; PALLELA VR; KOLAN H; DUGGARAJU R; MAISH D; SRIVASTAVA S
      IMPROVED ANTIBODY TARGETING WITH INTERFERON-ALPHA-2B CONJUGATE

      Journal of immunotherapy with emphasis on tumor immunology
    43. HRELIA P; TANNEBERGER S
      IMMUNOPREVENTION OF CANCER POSES A CHALLENGE TO PHARMACOLOGICAL RESEARCH

      Pharmacological research
    44. ARIMOTO Y; CHUNG YS; YAMADA N; OKUNO M; SOWA M
      INTRASPLENIC COMBINATION IMMUNOTHERAPY WITH OK-432 AND INTERLEUKIN-2 ON LIVER METASTASIS OF COLORECTAL-CARCINOMA IN A MOUSE MODEL

      International journal of oncology
    45. VANOOSTEROM A
      IMPROVING CANCER SURVIVAL IN THE NEXT CENTURY

      European journal of cancer
    46. KUMAE T; SABURI Y; NASU M
      IN-VIVO AND IN-VITRO EFFECTS OF SIZOFIRAN ON THE HUMAN NEUTROPHILS AND THE SERUM OPSONIC ACTIVITY

      Biotherapy
    47. VUCKOVICDEKIC L; STANOJEVICBAKIC N; RAJNER L; DEKIC M; PESIC M
      IMMUNOMODULATION IN-VITRO - THE PREDICTIVE VALUE OF IN-VITRO TESTING OF LUNG-CANCER PATIENTS LYMPHOCYTE RESPONSIVENESS TO STIMULATION BY THYMEX-L - A PRELIMINARY-REPORT

      Journal of experimental & clinical cancer research
    48. PIGA A; GIORDANI P; QUATTRONE A; GIULIONI M; DESIGNORIBUS G; ANTOGNOLI S; CELLERINO R
      A PHASE-II STUDY OF INTERFERON-ALPHA AND LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 IN ADVANCED RENAL-CELL CARCINOMA

      Cancer immunology and immunotherapy
    49. TAHA SM; TABBARA KS
      MODULATION OF THE IMMUNE-RESPONSE OF BALB C MICE AGAINST LEISHMANIA-MAJOR BY IMUVERT/

      International journal of immunopharmacology
    50. BADAMCHIAN M; MORA CA; BAUMANN CA; PAINO JE; GOLDSTEIN AL
      BIODISTRIBUTION OF SYNTHETIC THYMOSIN ALPHA(1) IN THE SERUM, URINE AND MAJOR ORGANS OF MICE

      International journal of immunopharmacology
    51. KALDENNEMETH D; GREBMEIER J; ANTONI C; MANGER B; WOLF F; KALDEN JR
      NMR MONITORING OF RHEUMATOID-ARTHRITIS PATIENTS RECEIVING ANTI-TNF-ALPHA MONOCLONAL-ANTIBODY THERAPY

      Rheumatology international
    52. GARACI E; PICA F; RASI G; PALAMARA AT; FAVALLI C
      COMBINATION THERAPY WITH BRMS IN CANCER AND INFECTIOUS-DISEASES

      Mechanism of ageing and development
    53. KIM S; HAAS GP; HILLMAN GG
      DEVELOPMENT OF IMMUNOTHERAPY FOR THE TREATMENT OF MALIGNANCIES REFRACTORY TO CONVENTIONAL THERAPIES

      Cytokines and molecular therapy
    54. LI JH; MERTON DA; DUGGARAJU R; THAKUR ML
      AUGMENTING OF TUMOR UPTAKE OF ANTIMELANOMA ANTIBODY MEM136 - INFLUENCE OF INTERFERON

      Nuclear medicine and biology
    55. GRIDLEY DS
      THE ROLE OF CYTOKINES IN RADIATION-THERAPY FOR CANCER

      The Cancer journal
    56. TABATA A; KANEDA K; WATANABE H; ABO T; YANO I
      KINETICS OF ORGAN-ASSOCIATED NATURAL-KILLER-CELLS AND INTERMEDIATE CD3 CELLS DURING PULMONARY AND HEPATIC GRANULOMATOUS INFLAMMATION-INDUCED BY MYCOBACTERIAL CORD FACTOR

      Microbiology and immunology
    57. GULLO A; BERLOT G
      INGREDIENTS OF ORGAN DYSFUNCTION OR FAILURE

      World journal of surgery
    58. ASAI K; KATO H; KIMURA S; MUKAI S; KAWAHITO Y; SANO H; KONDO M; AKAOGI K; HIROSE K
      INDUCTION OF GENE-EXPRESSION FOR NITRIC-OXIDE SYNTHASE BY IMMUNOMODULATING DRUGS IN THE RAW264.7 MURINE MACROPHAGE CELL-LINE

      Cancer immunology and immunotherapy
    59. OOSTERHOF GON; CORNEL EB; SMITS GAHJ; DEBRUYNE FMJ; SCHALKEN JA
      THE INFLUENCE OF HIGH-ENERGY SHOCK-WAVES ON THE DEVELOPMENT OF METASTASES

      Ultrasound in medicine & biology
    60. ROSELLI M; GUADAGNI F; BUONOMO O; BELARDI A; FERRONI P; DIODATI A; ANSELMI D; CIPRIANI C; CASCIANI CU; GREINER J; SCHLOM J
      TUMOR-MARKERS AS TARGETS FOR SELECTIVE DIAGNOSTIC AND THERAPEUTIC PROCEDURES

      Anticancer research
    61. VASSILEV M; ANTONOV K; THEOCHAROV P; KRASTEV Z
      EFFECTS OF LOW-MOLECULAR-WEIGHT GLYCOPROTEINS IN CHRONIC HEPATITIS-B

      Hepato-gastroenterology
    62. VETVICKA V; THORNTON BP; ROSS GD
      SOLUBLE BETA-GLUCAN POLYSACCHARIDE BINDING TO THE LECTIN SITE OF NEUTROPHIL OR NATURAL-KILLER-CELL COMPLEMENT RECEPTOR-TYPE-3 (CD11B CD18) GENERATES A PRIMED STATE OF THE RECEPTOR CAPABLE OF MEDIATING CYTOTOXICITY OF IC3B-OPSONIZED TARGET-CELLS/

      The Journal of clinical investigation
    63. VAQUERO J; ZURITA M; OYA S; COCA S
      GANGLIOSIDES MODULATE THE GROWTH-RATE AND CELL PHENOTYPE OF A MURINE PRIMITIVE NEURO-ECTODERMAL TUMOR

      Acta neurochirurgica
    64. STEIN U; WALTHER W; SHOEMAKER RH
      REVERSAL OF MULTIDRUG-RESISTANCE BY TRANSDUCTION OF CYTOKINE GENES INTO HUMAN COLON-CARCINOMA CELLS

      Journal of the National Cancer Institute
    65. KASI LP; LAMKI LM; SARANTI S; PODOLOFF DA; FREEDMAN RS
      IN-111 LABELED LEUKOCYTES IN EVALUATION OF ACTIVE SPECIFIC IMMUNOTHERAPY RESPONSES

      International journal of gynecological cancer
    66. WAGSTAFF J
      THE ROLE OF BIOLOGICAL RESPONSE MODIFIERS IN THE MANAGEMENT OF PATIENTS WITH COLORECTAL-CANCER

      European journal of cancer
    67. CORNEL EB; SMITS GAHJ; DEBRUYNE FMJ; HEERSCHAP A; SCHALKEN JA; OOSTERHOF GON
      THE EFFECTS OF SUCCESSIVE HIGH-ENERGY SHOCK-WAVE TUMOR ADMINISTRATIONON TUMOR BLOOD-FLOW

      Ultrasound in medicine & biology
    68. IACOBELLI S; GARUFI C; IRTELLI L; MARTINO MT; SANTOBUONO F; VICARIO G; TINARI N; FIORENTINO B; INNOCENTI P; NATOLI C
      A PHASE-I STUDY OF RECOMBINANT INTERFERON-ALPHA ADMINISTERED AS A 7-DAY CONTINUOUS VENOUS INFUSION AT CIRCADIAN-RHYTHM MODULATED RATE IN PATIENTS WITH CANCER

      American journal of clinical oncology
    69. KLEINFRANKE A; ANDERER FA
      IL-12-MEDIATED ACTIVATION OF MHC-UNRESTRICTED CYTOTOXICITY OF HUMAN PBMC SUBPOPULATIONS - SYNERGIC ACTION OF A PLANT RHAMNOGALACTURONAN

      Anticancer research
    70. OKA M; HAZAMA S; SUZUKI M; OGURA Y; KOBAYASHI N; SUZUKI T
      HISTOLOGICAL ANALYSIS OF HEPATOCELLULAR-CARCINOMA TREATED BY INTRAARTERIAL COMBINED IMMUNOCHEMOTHERAPY

      Hepato-gastroenterology
    71. OKUNO K; YASUTOMI M
      LOCOREGIONAL IMMUNOCHEMOTHERAPY IN LIVER-CARCINOMA - PRESENT AND FUTURE

      Hepato-gastroenterology
    72. CALABRESI F; GAMUCCI T
      BIOLOGICAL RESPONSE MODIFIERS

      Lung cancer
    73. SIDWELL RW; SMEE DF; HUFFMAN JH; BAILEY KW; WARREN RP; BURGER RA; PENNEY CL
      ANTIVIRAL ACTIVITY OF AN IMMUNOMODULATORY LIPOPHILIC DESMURAMYL DIPEPTIDE ANALOG

      Antiviral research
    74. SHIRATORI Y; KAWASE T; NAKATA R; TANAKA M; HIKIBA Y; OKANO KI; MATSUMURA M; NIWA Y; KOMATSU Y; SHIINA S; OMATO M
      EFFECT OF SPLENECTOMY ON HEPATIC METASTASIS OF COLON-CARCINOMA AND NATURAL-KILLER ACTIVITY IN THE LIVER

      Digestive diseases and sciences
    75. WALLACE PK; EISENSTEIN TK; MEISSLER JJ; MORAHAN PS
      DECREASES IN MACROPHAGE-MEDIATED ANTITUMOR-ACTIVITY WITH AGING

      Mechanism of ageing and development
    76. MANI S; TODD MB; KATZ K; POO WJ
      PROGNOSTIC FACTORS FOR SURVIVAL IN PATIENTS WITH METASTATIC RENAL-CANCER TREATED WITH BIOLOGICAL RESPONSE MODIFIERS

      The Journal of urology
    77. TAKAHASHI H; NAKADA T; NAKAKI M; WANDS JR
      INHIBITION OF HEPATIC METASTASES OF HUMAN COLON-CANCER IN NUDE-MICE BY A CHIMERIC SF-25 MONOCLONAL-ANTIBODY

      Gastroenterology
    78. LI J; MERTON DA; THAKUR ML; BARR J; WILDER S; OHARA MD; GIBBONS G; GOLDBERG B
      INFLUENCE OF BIOLOGICAL RESPONSE MODIFIERS - MEASUREMENT OF TUMOR BLOOD-FLOW AND TEMPERATURE

      Journal of immunotherapy with emphasis on tumor immunology
    79. JACOBSEN MB; BRATLIE J; BRUNBORG G; HANSSEN LE
      INTERFERON-ALPHA-2B ALONE AND COMBINED WITH OCTREOTIDE IN PRIMARY CARCINOID CELL-CULTURES

      Oncology Reports
    80. JAPEL M; LOTZERICH H; ROGALLA K
      ROLE OF ACETYLSALICYLIC-ACID IN CYTOKINE STIMULATION OF MACROPHAGES IN ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY (ADCC)

      Mediators of inflammation
    81. SMITS GAHJ; CORNEL EB; VANDEBOOGERT E; OOSTERHOF GON; DEBRUYNE FMJ; SCHALKEN JA; HEERSCHAP A
      EFFECTS OF HIGH-ENERGY SHOCK-WAVES ON TUMOR BLOOD-FLOW AND METABOLISM- P-31 H-1/H-2 NUCLEAR-MAGNETIC-RESONANCE STUDY/

      NMR in biomedicine
    82. WALLACE PK; MORAHAN PS
      ROLE OF MACROPHAGES IN THE IMMUNOTHERAPY OF LEWIS LUNG PERITONEAL CARCINOMATOSIS

      Journal of leukocyte biology
    83. TUROWSKI RC; TRIOZZI PL
      APPLICATION OF CHEMICAL IMMUNOMODULATORS TO THE TREATMENT OF CANCER AND AIDS

      Cancer investigation
    84. BAIER JE; NEUMANN HA; TAUFIGHICHIRAZI T; GALLATI H; RICKEN D
      THYMOPENTIN, FACTOR AF2, AND POLYERGA IMPROVE IMPAIRED MITOGEN-INDUCED INTERFERON-GAMMA RELEASE OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS DERIVED FROM TUMOR PATIENTS

      Tumordiagnostik & Therapie
    85. SEITZ JF
      BIOLOGICAL RESPONSE MODIFIERS AS ADJUVANT TREATMENT IN GASTROINTESTINAL CANCER

      Gastroenterologie clinique et biologique
    86. BOKEMEYER C; HARSTRICK A; SCHMOLL HJ
      TREATMENT OF ADULT SOFT-TISSUE SARCOMAS WITH DOSE-INTENSIFIED CHEMOTHERAPY AND HEMATOPOIETIC GROWTH-FACTORS

      Onkologie
    87. OKA M; HAZAMA S; YOSHINO S; SHIMODA K; SUZUKI M; SHIMIZU R; YANO K; NISHIDA M; SUZUKI T
      INTRAARTERIAL COMBINED IMMUNOCHEMOTHERAPY FOR UNRESECTABLE HEPATOCELLULAR-CARCINOMA - PRELIMINARY-RESULTS

      Cancer immunology and immunotherapy
    88. KANEDA K; PILARO AM; SAYERS TJ; NAGASHIMA K; GONDA MA; ORTALDO JR; WILTROUT RH
      QUANTITATIVE-ANALYSIS OF ROD-CORED VESICLES AND DENSE GRANULES OF LARGE GRANULAR LYMPHOCYTES IN THE LIVER, SPLEEN, AND PERIPHERAL-BLOOD OF RATS

      Cell and tissue research
    89. NIELL HB; MAUER AM; RADEMACHER D
      CYTOTOXIC EFFECTS OF ALPHA-INTERFERON AND GAMMA-INTERFERON AND TUMOR-NECROSIS-FACTOR IN HUMAN BLADDER-TUMOR CELL-LINES

      Urological research
    90. WONG CK; LEUNG KN; FUNG KP; CHOY YM
      IMMUNOMODULATORY AND ANTITUMOR POLYSACCHARIDES FROM MEDICINAL-PLANTS

      Journal of international medical research
    91. DEREIJKE TM; SCHAMHART DH; KURTH KH; LOWIK CW; DONKERS LH; STERENBORG HJ
      TUMOR-GROWTH DELAY BY LASER-GENERATED SHOCK-WAVES

      Lasers in surgery and medicine
    92. ZHU HG; ZOLLNER TM; KLEINFRANKE A; ANDERER FA
      ENHANCEMENT OF MHC-UNRESTRICTED CYTOTOXIC ACTIVITY OF HUMAN CD56- NATURAL-KILLER (NK) CELLS AND CD3+ T-CELLS BY RHAMNOGALACTURONAN - TARGET-CELL SPECIFICITY AND ACTIVITY AGAINST NK-INSENSITIVE TARGETS( CD3)

      Journal of cancer research and clinical oncology
    93. KIRSCH M; FISCHER H; SCHACKERT G
      ACTIVATED MONOCYTES KILL MALIGNANT BRAIN-TUMOR CELLS IN-VITRO

      Journal of neuro-oncology
    94. BULGER K; PADUA F; DUFF R; PIHAN G; NICHOLS J; MURPHY J; MCCAFFREY R
      PHA INDUCES IL-2 RECEPTORS ON B-CLL CELLS AND IS A POTENTIAL BIOLOGICAL RESPONSE MODIFIER FOR THE LIL-2-DIPHTHERIA TOXIN, DAB(486)IL-2

      Leukemia research
    95. SNYDER EL
      TRANSFUSION REACTIONS - STATE-OF-THE-ART 1994

      Vox sanguinis
    96. SEIDL M; STEINBACH P; WORLE K; HOFSTADTER F
      INDUCTION OF STRESS FIBERS AND INTERCELLULAR GAPS IN HUMAN VASCULAR ENDOTHELIUM BY SHOCK-WAVES

      Ultrasonics
    97. CORNEL EB; OOSTERWIJK E; VANDESTREEK JD; GRUTTERS G; DEBRUYNE FMJ; SCHALKEN JA; OOSTERHOF GON
      HIGH-ENERGY SHOCK-WAVES INDUCED INCREASE IN THE LOCAL CONCENTRATION OF SYSTEMICALLY GIVEN TNF-ALPHA

      The Journal of urology
    98. RACKLEY R; NOVICK A; KLEIN E; BUKOWSKI R; MCLAIN D; GOLDFARB D
      THE IMPACT OF ADJUVANT NEPHRECTOMY ON MULTIMODALITY TREATMENT OF METASTATIC RENAL-CELL CARCINOMA

      The Journal of urology
    99. HAMASUNA R; EIZURU Y; MINAMISHIMA Y
      INHIBITION BY IOTA-CARRAGEENAN OF THE SPREAD OF MURINE CYTOMEGALOVIRUS FROM THE PERITONEAL-CAVITY TO THE BLOOD-PLASMA

      Journal of General Virology
    100. BALBI B; AUFIERO A; PESCI A; ODDERA S; ZANON P; ROSSI GA; OLIVIERI D
      LOWER RESPIRATORY-TRACT INFLAMMATION IN CHRONIC-BRONCHITIS - EVALUATION BY BRONCHOALVEOLAR LAVAGE AND CHANGES ASSOCIATED WITH TREATMENT WITH IMMUCYTAL, A BIOLOGICAL RESPONSE MODIFIER

      Chest


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/10/20 alle ore 01:10:00